SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Imhof, CélineMesschendorp, A Lianne
van der Heiden, Marieke
Baan, Carla C
van der Molen, Renate G
Remmerswaal, Ester B M
de Vries, Rory D
Diavatopoulos, Dimitri A
Boerma, Annemarie
Bakker, Femke J
Oosterhout, Emily
Bemelman, Frederike J
Hilbrands, Luuk B
Reinders, Marlies E J
Gansevoort, Ron T
Sanders, Jan-Stephan
van Baarle, Debbie
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.Published in
Transplantation direct 2022;8(11):e1387PMID
36284929ae974a485f413a2113503eed53cd6c53
10.1097/TXD.0000000000001387
Scopus Count
Collections
Related articles
- Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.
- Authors: Bouwmans P, Messchendorp AL, Sanders JS, Hilbrands L, Reinders MEJ, Vart P, Bemelman FJ, Abrahams AC, van den Dorpel MA, Ten Dam MA, de Vries APJ, Rispens T, Steenhuis M, Gansevoort RT, Hemmelder MH, RECOVAC Collaborators
- Issue date: 2022 Feb 5
- Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients.
- Authors: Ohki Y, Kawabe M, Yamamoto I, Katsumata H, Nakada Y, Kobayashi A, Urabe F, Miki J, Yamada H, Kimura T, Matsuo N, Tanno Y, Horino T, Ohkido I, Yamamoto H, Yokoo T
- Issue date: 2022
- Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant.
- Authors: Sanders JSF, Lianne Messchendorp A, de Vries RD, Baan CC, van Baarle D, van Binnendijk R, Diavatopoulos DA, Geers D, Schmitz KS, van Kessel CHG, Hartog GD, Kho MM, Koopmans MP, van der Molen RG, Remmerswaal EB, Rots N, Gansevoort RT, Bemelman FJ, Hilbrands LB, Reinders ME, RECOVAC Collaborators
- Issue date: 2022 Jul 7
- Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination.
- Authors: Al Jurdi A, Gassen RB, Borges TJ, Solhjou Z, Hullekes FE, Lape IT, Efe O, Alghamdi A, Patel P, Choi JY, Mohammed MT, Bohan B, Pattanayak V, Rosales I, Cravedi P, Kotton CN, Azzi JR, Riella LV
- Issue date: 2022
- Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
- Authors: Reindl-Schwaighofer R, Heinzel A, Mayrdorfer M, Jabbour R, Hofbauer TM, Merrelaar A, Eder M, Regele F, Doberer K, Spechtl P, Aschauer C, Koblischke M, Paschen C, Eskandary F, Hu K, Öhler B, Bhandal A, Kleibenböck S, Jagoditsch RI, Reiskopf B, Heger F, Bond G, Böhmig GA, Strassl R, Weseslindtner L, Indra A, Aberle JH, Binder M, Oberbauer R
- Issue date: 2022 Feb 1